Cassava to discontinue development of Alzheimer's disease drug

Filana Therapeutics

25/03/2025 12:08

March 25 (Reuters) - Cassava Sciences SAVA.O said on Tuesday it will discontinue the development of its drug for Alzheimer's disease.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Savio D'Souza)

 ((Sriparna.Roy@thomsonreuters.com;))